These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 578918)

  • 21. Effect of butaclamol, a new neuroleptic, on serotoninergic mechanisms.
    Pugsley TA; Lippmann W
    J Pharm Pharmacol; 1977 Mar; 29(3):135-8. PubMed ID: 15075
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The contrasting actions of TRH and cycloheximide in altering the effects of centrally acting drugs: evidence for the non-involvement of dopamine sensitive adenylate cyclase.
    Green AR; Heal DJ; Grahame-Smith DG; Kelly PH
    Neuropharmacology; 1976 Oct; 15(10):591-9. PubMed ID: 825788
    [No Abstract]   [Full Text] [Related]  

  • 23. Time studies on the effects of tranylcypromine plus tryptophan on formation of tryptamine and 5-hydroxytryptamine in rat brain.
    Hay JL; McKim HR; Baker GB; Dewhurst WG
    Proc West Pharmacol Soc; 1982; 25():133-5. PubMed ID: 7122487
    [No Abstract]   [Full Text] [Related]  

  • 24. Tryptophan availability and brain protein synthesis.
    Blazek R; Shaw DM
    Neuropharmacology; 1978 Dec; 17(12):1065-8. PubMed ID: 745695
    [No Abstract]   [Full Text] [Related]  

  • 25. The contribution of tryptamine to the behavioural effects of l-Tryptophan in tranylcypromine-treated rats.
    Marsden CA; Curzon G
    Psychopharmacology (Berl); 1978 Apr; 57(1):71-6. PubMed ID: 149328
    [No Abstract]   [Full Text] [Related]  

  • 26. Electroconvulsive shock increases the behavioural responses of rats to brain 5-hydroxytryptamine accumulation and central nervous system stimulant drugs.
    Evans JP; Grahame-Smith DG; Green AR; Tordoff AF
    Br J Pharmacol; 1976 Feb; 56(2):193-9. PubMed ID: 3248
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Some observations on the behavioural and biochemical effects of L-tryptophan plus a monoamine oxidase inhibitor in immature rats [proceedings].
    Atterwill CK; Costain DW; Green AR
    Br J Pharmacol; 1979 May; 66(1):118P-119P. PubMed ID: 454914
    [No Abstract]   [Full Text] [Related]  

  • 28. Role of tryptaminergic mechanisms in the elements of the behavioural syndrome evoked by tryptophan and a monoamine oxidase inhibitor [proceedings].
    Crow TJ; Deakin JF
    Br J Pharmacol; 1977 Mar; 59(3):461P. PubMed ID: 843707
    [No Abstract]   [Full Text] [Related]  

  • 29. Role of tryptamine in the behavioural changes caused by a monoamine oxidase inhibitor and L-tryptophan [proceedings].
    Curzon G; Marsden CA
    Br J Pharmacol; 1977 Jun; 60(2):307P-308P. PubMed ID: 880472
    [No Abstract]   [Full Text] [Related]  

  • 30. Evidence for dopamine deamination by both type A and type B monoamine oxidase in rat brain in vivo and for the degree of inhibition of enzyme necessary for increased functional activity of dopamine and 5-hydroxytryptamine.
    Green AR; Mitchell BD; Tordoff AF; Youdim MB
    Br J Pharmacol; 1977 Jul; 60(3):343-9. PubMed ID: 890205
    [No Abstract]   [Full Text] [Related]  

  • 31. beta-Adrenoceptor antagonists inhibit the behavioural responses of rats to increased brain 5-hydroxytryptamine.
    Costain DW; Green AR
    Br J Pharmacol; 1978 Oct; 64(2):193-200. PubMed ID: 30503
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction of c-fos in rat forebrain by pharmacological manipulation of 5-hydroxytryptamine levels.
    Moorman JM; Jackson A; Grahame-Smith DG; Leslie RA
    Neuroscience; 1995 Oct; 68(4):1089-96. PubMed ID: 8544984
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protein synthesis inhibition and amnesia for saccharin aversion memory in rats after intra-cisternal administration of cycloheximide.
    Tucker AR; Oei TP
    Physiol Behav; 1982 Jun; 28(6):1025-8. PubMed ID: 7202221
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects in the suckling rat of chronic treatment with tryptophan and a monoamine oxidasee inhibitor.
    Tricklebank MD; Adlard BP
    Exp Neurol; 1974 Oct; 45(1):79-93. PubMed ID: 4413109
    [No Abstract]   [Full Text] [Related]  

  • 35. TRH potentiates behavioural changes following increased brain 5-hydroxytryptamine accumulation in rats.
    Green AR; Grahame-Smith DG
    Nature; 1974 Oct; 251(5475):524-6. PubMed ID: 4214262
    [No Abstract]   [Full Text] [Related]  

  • 36. Cycloheximide blocks the fall of plasma and tissue tryptophan levels after tryptophan-free amino acid mixtures.
    Moja EA; Restani P; Corsini E; Stacchezzini MC; Assereto R; Galli CL
    Life Sci; 1991; 49(15):1121-8. PubMed ID: 1895873
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of tranylcypromine and pargyline on brain tryptamine.
    Tabakoff B; Moses F; Philips SR; Boulton AA
    Experientia; 1977 Mar; 33(3):380-1. PubMed ID: 870336
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Behavioural hyperactivity in rats treated with selective monoamine oxidase inhibitors and LM 5008, a selective 5-hydroxytryptamine uptake blocker.
    Ashkenazi R; Finberg JP; Youdim MB
    Br J Pharmacol; 1983 Jul; 79(3):765-70. PubMed ID: 6418248
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of cycloheximide and puromycin on glycosyltransferases of microsomal fractions from rat brain.
    Shah SN; Peterson NA
    Biochim Biophys Acta; 1971 Jun; 239(1):126-31. PubMed ID: 5569936
    [No Abstract]   [Full Text] [Related]  

  • 40. The biphasic effect of small doses of tranylcypromine on the spontaneous motor activity and learned conditioned behaviour in rats.
    Bucci L
    Pharmacology; 1974; 12(6):354-61. PubMed ID: 4456428
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.